Now available OnDemand

Jaydev Thakkar

Chief Operating Officer at Biofourmis

Jaydev currently leads Biofourmis global operations across various business functions, including Customer Success, Sales and Marketing Operations, Clinical Research Operations and Supply chain. Jaydev has over 25 years of experience in leadership roles at organizations that include fortune 100 companies and rapidly growing start-ups. Prior to Biofourmis, Jaydev was instrumental in founding a Digital Health and Innovation group at world’s leading biotech, Amgen, where he served for 14 years. During this time, he led its “beyond the therapy” digital innovation strategy to maximize product value and clinical outcomes across the patient journey—from clinical development through product launch and post-marketing. At Amgen, Jaydev also led information technology operations for the company’s large portfolio of global clinical trials—including some of the largest ever in the industry, with more than 27,000 participants across 50 countries and more than 1,000 sites. Before Amgen, Jaydev was a telecommunications, technology and finance consultant who co-founded a technology startup and also managed his family’s manufacturing business in India.

Christopher Leggett

Head of Global Commercial Innovation at Genmab

Christopher Leggett is the Head of Global Commercial Innovation at Genmab. Genmab is a biotechnology company specializing in the creation and development of novel antibody therapies targeting cancer and other serious diseases. As the Lead for Global Commercial Innovation, Chris is responsible for identifying and implementing differentiated capabilities to enhance provider and patient experience. He is focused on leveraging digital health solutions to transform the customer journey from clinical development through commercialization.
Chris has extensive industry experience in marketing, public policy, market access, and healthcare innovation. Prior to joining Genmab, he led the Immunology Market Access Marketing team at Janssen and established the Commercial Innovation function at Novo Nordisk, Inc. Chris earned a BA in Political Science and MBA from Loyola University Maryland.